Feb 8, 2021, 01:00 by User Not Found

Clinical Research News | The pandemic has had potentially far-reaching effects on the treatment of cancer patients and conduct of oncology clinical trials, according to panelists presenting at last week’s COVID-19 and Cancer virtual meeting of the American Association for Cancer Research. While the medical community seems to favor extending “interim” policies related to telehealth and study enrollment, it also worries about the unintended consequences of institutional safety precautions—notably, delays in patients getting needed care.

Feb 5, 2021, 01:00 by User Not Found

Clinical Research News I Social distancing benefits the individual and community, airborne transmission contributed significantly to cruise ship outbreak, viral load likely peaks at symptom onset, Plus: NIH funds study to identify risk factors for severe COVID-19 in children and BioNTech-Pfizer’s COVID-19 vaccine largely effective against B.1.1.7 variant.

Feb 3, 2021, 01:10 by User Not Found

Clinical Research News | On behalf of Clinical Research News, Bridget Kotelly spoke with Teri Takle-Flach of Boston Scientific about the biggest challenges planning clinical studies today and the impact EU Medical Device Regulation.

Feb 2, 2021, 01:00 by User Not Found

Clinical Research News | A computer scientist at The Ohio State University (OSU) recently demonstrated the potential of artificial intelligence to crunch real-world data and emulate randomized clinical trials, speeding the pace of drug repurposing.

Jan 29, 2021, 01:00 by User Not Found

Clinical Research News I Cluster randomized trials could help children return safely to schools, early anticoagulation therapy does not improve outcomes, recovered patients experience lasting effects. Plus: NIH launches database to track COVID-19 related neurological symptoms and 86% of doctors believe mental health, depression will be biggest non-COVID-19 public health issue.

Jan 28, 2021, 01:00 by User Not Found

Clinical Research News | Strategic collaborations to enable more diverse trial populations, advance combinatorial intravesical immunotherapy, and engage patients in a privacy-centric way. Plus: new partnership program for CROs and an Oracle integration for Cognizant’s Shared Investigator Platform.

Jan 27, 2021, 14:55 by

Calyx Medical Imaging and other eClinical services provide critical support for clinical development programs to deliver much-needed therapies to market

Jan 27, 2021, 14:55 by

Jan 27, 2021, 14:55 by

Syntekabio has announced a strategic collaboration with Hanmi Science to co-develop breakthrough COVID-19 treatments using drug repositioning technologies.

Jan 27, 2021, 14:55 by

Medical communications company, Prime Global, and healthcare technology company, Raremark®, announced today that they have formed a strategic partnership to transform solutions for patients with rare diseases. Together, the companies will uncover insights into the entire patient journey that will allow the creation of truly patient-centric drug development and commercialisation programs. Focusing on the needs of patients is the key to powerful communications that make a tangible difference to patient outcomes.

Jan 27, 2021, 14:55 by

CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced that its Risk-Based Quality Management (RBQM) platform has been critical in supporting numerous Pharmaceutical companies and CROs to interrogate data in their global COVID-19 vaccine and antiviral antibody trials to ensure data quality and integrity.

Jan 27, 2021, 14:55 by

Jan 27, 2021, 14:55 by

To accelerate drug development, MedAI, an expert of AI-assisted R&D research company, announces that it has completed the construction of its Artificial Intelligence Drug Discovery (AIDD) Platform. With this platform, scientists at MedAI are now capable of providing innovative solutions for pharmaceutical companies to push forward their drug discovery projects.

Jan 27, 2021, 14:55 by

Pyridinium ionic liquids are widely applied in Diels-Alder reaction, Friedel-Crafts reaction, Suzuki reaction, Grignard Reaction as well as the synthesis of some pharmaceutical agents. To meet the growing needs for this type of chemicals, Alfa Chemistry recently announced to provide wide choices of pyridinium ionic liquids for clients both at home and abroad. Most of them are in stock and can be delivered to buyers within a few business days.

Jan 27, 2021, 14:55 by

Today, eNUVIO has announced the launch of their latest innovative microfluidic device for neuronal compartmentalization and co-culture experiments — the OMEGA-96. This first of its kind microplate will help to improve the success and efficiency of drug discovery and safety toxicology in neurological research areas, particularly in the field of neurodegenerative and neuromuscular diseases.

Jan 27, 2021, 14:55 by

Year one of The Duchenne Registry powered by THREAD’s decentralized platform sees uptick in survey completion, data collection, and community engagement

Jan 26, 2021, 16:27 by User Not Found

Clinical Research News | Nothing quite tests a risk-based management approach like a global pandemic that few predicted. And for Pfizer’s Melissa Suprin, the COVID-19 pandemic was the first big test of the quality management system.

Jan 22, 2021, 10:19 by User Not Found

Clinical Research News| The UK’s patient stratification score doesn’t hold up to scrutiny, Fauci and others encourage doctors to equip themselves to argue for vaccines, NIH launches a study of “Long COVID”, and more. Plus: Siemens, with German funding, sets up more COVID-19 treatment facilities for South Africa.

Jan 21, 2021, 14:26 by User Not Found

Clinical Research News | Fundamental aging processes appear to be root-cause contributors to multiple conditions, ranging from heart attacks and cancer to neurodegenerative disorders like Alzheimer’s disease. Now a series of clinical trials will look at whether senolytics— drugs targeting cellular aging—could affect many or perhaps all other aging mechanisms because they are interlinked.

Jan 19, 2021, 11:32 by

These studies, which are funded by the American Heart Association, will use wearable sensors to increase knowledge of the links between brain and heart health.